OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardioprotective Roles of Endothelial Progenitor Cell-Derived Exosomes
Caiyu Zeng, Jia Xu, Xin Liu, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine
Daniela Lopes, Joana Lopes, Miguel Pereira‐Silva, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 38

Endothelial Progenitor Cells as Biomarkers of Cardiovascular Pathologies: A Narrative Review
Paul Philipp Heinisch, Corina Bello, Maximilian Y. Emmert, et al.
Cells (2022) Vol. 11, Iss. 10, pp. 1678-1678
Open Access | Times Cited: 30

Optimization of exosome-based cell-free strategies to enhance endogenous cell functions in tissue regeneration
Siyan Deng, Hongfu Cao, Xiaolin Cui, et al.
Acta Biomaterialia (2023) Vol. 171, pp. 68-84
Open Access | Times Cited: 20

Exosomes of endothelial progenitor cells repair injured vascular endothelial cells through the Bcl2/Bax/Caspase-3 pathway
Wei Tan, Yanling Li, Lu Ma, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6

Exosome-Based Therapy in Cardiovascular Diseases: A New Frontier in Cardiovascular Disease Treatment
Cheong-Whan Chae, Gun Choi, Tae Ho Yoon, et al.
Korean Circulation Journal (2025) Vol. 55
Closed Access

Endothelial progenitor cells in the host defense response
Xin Shi, Kelly A. Seidle, Kevin J. Simms, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108315-108315
Open Access | Times Cited: 19

IL-35 ameliorates lipopolysaccharide-induced endothelial dysfunction by inhibiting endothelial-to-mesenchymal transition
Jie Feng, Kai Li, Feng Xie, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111567-111567
Closed Access | Times Cited: 4

Targeting angiogenesis in myocardial infarction: Novel therapeutics (Review)
Jiejie Li, Yuanyuan Zhao, Wei Zhu
Experimental and Therapeutic Medicine (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 26

Multibiofunctional TFEB-engineered endothelial progenitor cell-derived extracellular vesicles/hydrogel system for rescuing critical limb ischemia
Chen Zhao, Xing Zheng, Xinbo Wei, et al.
Chemical Engineering Journal (2023) Vol. 460, pp. 141730-141730
Closed Access | Times Cited: 10

Endothelial-to-Mesenchymal Transition: Potential Target of Doxorubicin-Induced Cardiotoxicity
Jie Feng, Yanqing Wu
American Journal of Cardiovascular Drugs (2023) Vol. 23, Iss. 3, pp. 231-246
Closed Access | Times Cited: 8

Non-Exosomal and Exosome-Derived miRNAs as Promising Biomarkers in Canine Mammary Cancer
Patrícia Petroušková, Nikola Hudáková, Marcela Maloveská, et al.
Life (2022) Vol. 12, Iss. 4, pp. 524-524
Open Access | Times Cited: 13

Engagement of the CXCL12–CXCR4 Axis in the Interaction of Endothelial Progenitor Cell and Smooth Muscle Cell to Promote Phenotype Control and Guard Vascular Homeostasis
Sebastian F. Mause, Elisabeth Ritzel, Annika Deck, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 867-867
Open Access | Times Cited: 11

Circulatory long noncoding RNAs (circulatory-LNC-RNAs) as novel biomarkers and therapeutic targets in cardiovascular diseases: Implications for cardiovascular diseases complications
Seyed Mahdi Emami Meybodi, Nafiseh Soleimani, Abolfazl Yari, et al.
International Journal of Biological Macromolecules (2022) Vol. 225, pp. 1049-1071
Closed Access | Times Cited: 11

The Long Telling Story of “Endothelial Progenitor Cells”: Where Are We at Now?
Maria Cristina Vinci, Ermes Carulli, Erica Rurali, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 112-112
Open Access | Times Cited: 11

Endothelial progenitor cell-derived small extracellular vesicles for Myocardial angiogenesis and revascularization
Maher T Al-Omar, Mahmoud T Alnajjar, Ziyad T. Ahmed, et al.
Journal of Clinical and Translational Research (2022)
Open Access | Times Cited: 10

Applying Principles of Regenerative Medicine to Vascular Stent Development
S. Prakash Parthiban, Michael Rafuse, Richard Johnson, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 8

Endothelial progenitor cells for diabetic cardiac and kidney disease
Matthew J. Raleigh, Sachin V. Pasricha, Aaron Nauth, et al.
Stem Cells Translational Medicine (2024) Vol. 13, Iss. 7, pp. 625-636
Open Access | Times Cited: 1

Exosomes as Regulators of Macrophages in Cardiovascular Diseases
Marina Soriano-Cruz, Wendy Guadalupe Vázquez-González, Paula Molina-Vargas, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2683-2683
Open Access | Times Cited: 1

Research progress of exosomes as drug carriers in cancer and inflammation
Qixiang Feng, Yu Zhang, Yuelin Fang, et al.
Journal of drug targeting (2022) Vol. 31, Iss. 4, pp. 335-353
Closed Access | Times Cited: 6

Exosomes for gene therapy effectively inhibit the endothelial-mesenchymal transition in mouse aortic endothelial cells
Zhenyuan Wei, Yang Zhao, Peichun Hsu, et al.
BMC Musculoskeletal Disorders (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 6

MicroRNA-126 Regulates Thrombosis Through Endothelial Progenitor Cells
Qian Xiao, Dan Wang, Yingda Sheng, et al.
DNA and Cell Biology (2023) Vol. 42, Iss. 6, pp. 315-321
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top